BPDCN

Clinical trials for BPDCN explained in plain language.

Never miss a new study

Get alerted when new BPDCN trials appear

Sign up with your email to follow new studies for BPDCN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Engineered immune cells take aim at tough childhood leukemias

Disease control Recruiting now

This early-phase trial tests a new treatment called CD123-CAR T cells for children and young adults up to age 21 with certain blood cancers (AML, MDS, ALL, or BPDCN) that have come back or not responded to standard therapy. The treatment involves collecting the patient's own immu…

Matched conditions: BPDCN

Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control

Last updated May 06, 2026 16:03 UTC

BPDCN

Get alerted when new BPDCN trials appear

Engineered immune cells take aim at tough childhood leukemias